Clinical Trial

Impact of the Presence of the Corpus Luteum on Pregnancies Obtained Through Frozen Embryo Transfer(FET)

Study acronym: LUTI
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
In pregnancies achieved through programmed frozen embryo transfer cycle (PC-FET) and modified natural frozen embryo transfer (mNC-FET), to determine whether there are differences in endothelial and placental function, maternal cardiovascular function, fetal growth and fetal cardiovascular and cerebral programming and to assess whether there is an association between these differences and the plasma concentrations of the main secretion products of the Corpus Luteum (CL) with vasoactive and angiogenic action.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-24.
Status change: Active, Not Recruiting → Recruiting 2025-03-28
Trial Details
NCT Number NCT06896617
Lead Sponsor Fundacion Clinic per a la Recerca Biomédica
Conditions Infertilities, Embryo Transfer
Enrollment 334 participants
Start Date 2025-02-01
Primary Completion 2026-11-20 (estimated)
Study Completion 2026-12-20 (estimated)
Updated on ClinicalTrials.gov 2025-04-02